Junta editorial

Dr Susannah Stanway qualified from Bristol University in 1998 and subsequently obtained an MD thesis from Imperial College in 2009; her medical oncology training was undertaken at UCLH and Royal Marsden Hospital (RMH), UK. She completed an MSc thesis for her work on risk stratification to guide follow up after childhood malignancy. She has worked at consultant level since 2012. She is a past president of the Oncology Section at the Royal Society of Medicine. 

Susie’s principle research and education interests center around cancer control in low-middle income countries (LMICs). She has historically sat on the editorial board of ASCO’s Journal of Clinical Oncology Global Oncology ad has been on the editorial board of e-Cancer for 5 years. She has established and leads a sub-module on Global Cancer Control on the ICR’s MSc course. She also teaches on the UCH Global Health MSc course on cancer and has taught about cancer and global health on the LSHTM Global Health MSc course. She has actively contributed to oncology education of junior doctors by facilitating “train the trainers courses” in 4 countries in East Africa in a partnership between the East African Development Bank, the British Council and the Royal College of Physicians. The “Cancer Control in LMICs” conference held annually at the Royal Society of Medicine since 2016 became the annual London Global Cancer Week (LGCW https://www.lgcw.org.uk) in 2019 with over 30 meetings and events involving international groups involved in cancer care such as the UN agencies, The Commonwealth, the Lancet Oncology and Chatham House, London. She now sits on the steering committee of LGCW and is co-convenor. She has received awards from the Global Challenges Research Fund to study unmet need in women following breast cancer treatment Ghana and Tanzania and to help develop palliative care services in the DR Congo. She was the founder and has co-chaired the RMH/ICR Cancer Control in LMICs Collaborative Group focusing on research and education in low resource settings within the two institutions. She has co-led the establishment of the UK Global Cancer Network (https://www.ukgcn.org). She sits on the ECO inequalities network and has historically been in the ESMO global policy group. She has an interest in climate change and cancer and co-chairs the international group ex-USA Oncologists Unite for Climate Health (OUCH). She has recently studied Public Policy Analysis at the London School of Economics on a short course. 

Susie has also been actively involved in research and education around cancer survivorship. This includes the area of cardio-oncology, in collaboration with amongst others, the Cardio-Oncology Group at the Royal Brompton Hospital and the London School of Hygiene and Tropical Medicine (where she co-supervised a PhD student); treatment-induced Hot Flushes (where she sat on the NCRI Symptom Management Working Group); In 2017 she co-chaired and co-organised the Global Cardio-Oncology Summit in London, and has spoken at international cardio-oncology meetings in Florida and South Africa since; she also has had interests in sexual and psychological consequences of cancer and has worked on allied projects. She has historically co-chaired the RMH’s Living With and Beyond Cancer Committee, sat on the RM Partners Vanguard Survivorship pathway and set up and co-chaired a pan London Survivorship research group; She had an interest in digital tools for cancer patients and has co-led an early phase clinical trial evaluating a mobile phone app to help patients manage side effects on oral chemotherapy and also has participated in research on digital tools for patients to better navigate the cancer pathway.  She sits on the Development Board of Breast Cancer Now.